AG002HQD

189028-95-3 | 2-Oxazolidinone, 3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4S)-

AG002HQD

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	189028-95-3
Catalog Number	AG002HQD(AGN-PC-0QIB1M)
Chemical Name	2-Oxazolidinone, 3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4S)-
EC Number	606-165-0
IUPAC Name	(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
InChI	InChI=1S/C20H20FNO4/c21-16-11-9-15(10-12-16)18(23)7-4-8-19(24)22-17(13-26-20(22)25)14-5-2-1-3-6-14/h1-3,5-6,9-12,17-18,23H,4,7-8,13H2/t17-,18+/m1/s1
InChI Key	AVAZNWOHQJYCEL-MSOLQXFVSA-N
MDL Number	MFCD13194798
Molecular Formula	C20H20FNO4
Molecular Weight	357.3755
SMILES	O[C@@H](CCCC(=O)N1[C@H](COC1=O)C1=CC=CC=C1)C1=CC=C(F)C=C1
Synonyms	189028-95-3, (S)-3-((S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one, (4S)-3-[(5S)-5-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE, (4S)-3-[(5R)-5-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE, 2-Oxazolidinone, 3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4S)-, ezetimibe int a, AVAZNWOHQJYCEL-MSOLQXFVSA-N, AK109378, ezetimibe intermediates, Ezetimibe Intermediate-6, SCHEMBL515189, CTK0H1387, DTXSID50437685, (S)-3-[(S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-2-oxazolidinone, ACT07248, AMX10119, KS-00000PS3, MFCD13194798, ZINC22059525, AKOS015896433, DS-4317, AC-26981, AJ-80879, AN-30441, SC-86863, AB0005574, AX8226721, ST2402810, CS-0037017, FT-0656395, Y6621, 028F953, I06-2021, (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl, (4S)-3-[(5S)-5-(4-Fluoro-phenyl)-5-hydroxy-pentanoyl]-4-phenyl-oxazolidin-2-one, (4s)-3-[(5s)-5-(4-fluorophenyl)-5-hydroxy-1-oxo-pentyl]-4-phenyl-2-oxazolidinone, (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-pentanoyl]-4-phenyl-oxazolidin-2-one, (4S)-3-[(S)-5-Hydroxy-5-(4-fluorophenyl)valeryl]-4beta-phenyloxazolidine-2-one, (4s)-4-phenyl-3-[(5s)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-1,3-oxazolidin-2-one, 3-[(5s)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4s)- 2-oxazolidinone, (4S)-3-[(5R)-5-(4-FLUOROPHENYL)-5- HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE, Ezetimibe impurity (3-[5-(4-Fluoro-phenyl)-5-(S)-hydroxy-pentanoyl]-4-(R)-phenyl-oxazolidin-2-one), C20H20FNO4, ACN-039798, CID10269700, (4R)-3-[5-(4-fluorophenyl)-5-hydroxy-pentanoyl]-4-phenyl-1,3-oxazolidin-2-one, Ezetimibe intermediate;2-Oxazolidinone, 3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4S)-,

Complexity	486
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	2
Defined Bond Stereocenter Count	0
Exact Mass	357.138g/mol
Formal Charge	0
Heavy Atom Count	26
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	357.381g/mol
Monoisotopic Mass	357.138g/mol
Rotatable Bond Count	6
Topological Polar Surface Area	66.8A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	2.8

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number